Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Poor drug distribution as a possible explanation for the results of the PRECISE trial.

Sampson JH, Archer G, Pedain C, Wembacher-Schröder E, Westphal M, Kunwar S, Vogelbaum MA, Coan A, Herndon JE, Raghavan R, Brady ML, Reardon DA, Friedman AH, Friedman HS, Rodríguez-Ponce MI, Chang SM, Mittermeyer S, Croteau D, Puri RK; PRECISE Trial Investigators.

J Neurosurg. 2010 Aug;113(2):301-9. doi: 10.3171/2009.11.JNS091052.

PMID:
20020841
2.

Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning.

Sampson JH, Brady ML, Petry NA, Croteau D, Friedman AH, Friedman HS, Wong T, Bigner DD, Pastan I, Puri RK, Pedain C.

Neurosurgery. 2007 Feb;60(2 Suppl 1):ONS89-98; discussion ONS98-9.

PMID:
17297371
3.

Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions.

Sampson JH, Raghavan R, Brady ML, Provenzale JM, Herndon JE 2nd, Croteau D, Friedman AH, Reardon DA, Coleman RE, Wong T, Bigner DD, Pastan I, Rodríguez-Ponce MI, Tanner P, Puri R, Pedain C.

Neuro Oncol. 2007 Jul;9(3):343-53. Epub 2007 Apr 13.

4.

Convection-enhanced delivery in clinical trials.

Hall WA, Rustamzadeh E, Asher AL.

Neurosurg Focus. 2003 Feb 15;14(2):e2. Review.

PMID:
15727423
5.

Convection-enhanced delivery for the treatment of glioblastoma.

Vogelbaum MA, Aghi MK.

Neuro Oncol. 2015 Mar;17 Suppl 2:ii3-ii8. doi: 10.1093/neuonc/nou354. Review.

6.

Future of convection-enhanced delivery in the treatment of brain tumors.

Bidros DS, Liu JK, Vogelbaum MA.

Future Oncol. 2010 Jan;6(1):117-25. doi: 10.2217/fon.09.135. Review.

PMID:
20021213
7.

Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study.

Sewing AC, Caretti V, Lagerweij T, Schellen P, Jansen MH, van Vuurden DG, Idema S, Molthoff CF, Vandertop WP, Kaspers GJ, Noske DP, Hulleman E.

J Neurosci Methods. 2014 Dec 30;238:88-94. doi: 10.1016/j.jneumeth.2014.09.020. Epub 2014 Sep 27.

PMID:
25263805
8.

Salirasib (farnesyl thiosalicylic acid) for brain tumor treatment: a convection-enhanced drug delivery study in rats.

Goldberg L, Ocherashvilli A, Daniels D, Last D, Cohen ZR, Tamar G, Kloog Y, Mardor Y.

Mol Cancer Ther. 2008 Nov;7(11):3609-16. doi: 10.1158/1535-7163.MCT-08-0488.

9.

Convection and retro-convection enhanced delivery: some theoretical considerations related to drug targeting.

Motion JP, Huynh GH, Szoka FC Jr, Siegel RA.

Pharm Res. 2011 Mar;28(3):472-9. doi: 10.1007/s11095-010-0296-2. Epub 2010 Oct 21.

10.

A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma.

Barua NU, Hopkins K, Woolley M, O'Sullivan S, Harrison R, Edwards RJ, Bienemann AS, Wyatt MJ, Arshad A, Gill SS.

Drug Deliv. 2016;23(1):167-73. doi: 10.3109/10717544.2014.908248. Epub 2014 May 2.

PMID:
24786643
11.

Influence of an intratumoral cyst on drug distribution by convection-enhanced delivery: case report.

Ivasyk I, Morgenstern PF, Wembacher-Schroeder E, Souweidane MM.

J Neurosurg Pediatr. 2017 Sep;20(3):256-260. doi: 10.3171/2017.5.PEDS1774. Epub 2017 Jul 7.

PMID:
28686124
12.

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.

Kunwar S, Prados MD, Chang SM, Berger MS, Lang FF, Piepmeier JM, Sampson JH, Ram Z, Gutin PH, Gibbons RD, Aldape KD, Croteau DJ, Sherman JW, Puri RK; Cintredekin Besudotox Intraparenchymal Study Group.

J Clin Oncol. 2007 Mar 1;25(7):837-44.

PMID:
17327604
13.

Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies.

Kunwar S, Chang SM, Prados MD, Berger MS, Sampson JH, Croteau D, Sherman JW, Grahn AY, Shu VS, Dul JL, Husain SR, Joshi BH, Pedain C, Puri RK.

Neurosurg Focus. 2006 Apr 15;20(4):E15.

PMID:
16709020
14.

Magnetic Resonance Imaging-Based Assessment of Gadolinium-Conjugated Diethylenetriamine Penta-Acetic Acid Test-Infusion in Detecting Dysfunction of Convection-Enhanced Delivery Catheters.

van Putten EH, Wembacher-Schröder E, Smits M, Dirven CM.

World Neurosurg. 2016 May;89:272-9. doi: 10.1016/j.wneu.2016.02.003. Epub 2016 Feb 6.

PMID:
26862025
15.

Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model.

Kawakami K, Kawakami M, Kioi M, Husain SR, Puri RK.

J Neurosurg. 2004 Dec;101(6):1004-11.

PMID:
15597761
16.

Convection-enhanced delivery in the treatment of malignant glioma.

Lopez KA, Waziri AE, Canoll PD, Bruce JN.

Neurol Res. 2006 Jul;28(5):542-8. Review.

PMID:
16808887
17.

In vitro and in vivo testing of a novel recessed-step catheter for reflux-free convection-enhanced drug delivery to the brain.

Gill T, Barua NU, Woolley M, Bienemann AS, Johnson DE, S O'Sullivan, Murray G, Fennelly C, Lewis O, Irving C, Wyatt MJ, Moore P, Gill SS.

J Neurosci Methods. 2013 Sep 30;219(1):1-9. doi: 10.1016/j.jneumeth.2013.06.008. Epub 2013 Jul 5.

PMID:
23835009
18.

Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.

Anderson RC, Kennedy B, Yanes CL, Garvin J, Needle M, Canoll P, Feldstein NA, Bruce JN.

J Neurosurg Pediatr. 2013 Mar;11(3):289-95. doi: 10.3171/2012.10.PEDS12142. Epub 2012 Dec 14.

PMID:
23240851
19.

Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study.

Mueller S, Polley MY, Lee B, Kunwar S, Pedain C, Wembacher-Schröder E, Mittermeyer S, Westphal M, Sampson JH, Vogelbaum MA, Croteau D, Chang SM.

J Neurooncol. 2011 Jan;101(2):267-77. doi: 10.1007/s11060-010-0255-0. Epub 2010 Jun 20.

20.

Entry points for catheter placement in convection-enhanced delivery--a retrospective anatomic analysis.

Dörner L, Nabavi A, Mehdorn HM.

Minim Invasive Neurosurg. 2009 Oct;52(5-6):229-32. doi: 10.1055/s-0029-1243259. Epub 2010 Jan 14.

PMID:
20077363

Supplemental Content

Support Center